The aim of the study was to analyse the data obtained from a 2-year follow-up study of middle-aged Finnish subjects (n = 183) with a previous history of impaired glucose tolerance (IGT) in order to elucidate the longitudinal relationships between hypertension, fasting hyperinsulinaemia and obesity. Hypertension was defined as either a systolic blood pressure (BP) of у160 mm Hg or a diastolic BP of у95 mm Hg or being on antihypertensive medication regardless of the BP value. Multiple logistic regression analysis adjusted for glucose tolerance status, serum lipids, exercise behaviour and alcohol consumption shows that the odds ratios of
Introduction
Hypertension, obesity, and glucose intolerance (impaired glucose tolerance and non-insulin-dependent diabetes) are so commonly associated [1] [2] [3] [4] [5] [6] as to suggest common pathogenic mechanisms. There is a strong belief that hyperinsulinaemia is directly linked to hypertension, 1, 2 and insulin resistance has been observed among lean hypertensive patients. [6] [7] [8] However, some studies have failed to confirm these observations. 9, 10 Most of these studies were crosssectional in nature, and cause and effect were thus difficult to demonstrate.
Longitudinal and prospective studies on this issue are scarce. One prospective study revealed that after adjustment for overweight and body fat distribution, fasting insulin was an independent risk factor for hypertension only in subjects with normal body weight and normoglycaemia, 11 whereas another study showed that changes in blood pressure (BP) preceded abnormal glucose tolerance, but not hyperinsulinaemia. 4 A study made on non-obese young adult black men with the euglycaemic hyperinsulinaemic clamp technique suggested that insulin resistance might precede the onset of established essential hypertension. The aim of this study was to analyse the data obtained from a 2-year follow-up study of middleaged Finnish subjects with impaired glucose tolerance (IGT) and try to elucidate the longitudinal relationships between hypertension, fasting hyperinsulinaemia and obesity.
Subjects and methods
A screening survey for diabetes and the reasons for early retirement among the subjects born in 1935 and living in Oulu, a city of 100 000 inhabitants in northern Finland on 1 October 1990, was conducted from 15 October 1990 to 5 May 1992. In this survey, 207 subjects were defined as having IGT according to 2-h 75 g oral glucose tolerance tests (OGTTs) recommended by the WHO in 1985, 13 ie, a 2-h postload capillary whole blood glucose value of 7.8 to Ͻ11.1 mmol/l.
A follow-up study of the subjects with baseline IGT was carried out between 14 February and 9 June 1994, an average of 2.1 years (range 1.9 to 2.4) after the initial 2-h OGTTs. Of the 207 IGT subjects, 183 (84 men and 99 women) corresponding to 88.4% of the original group participated in the retest, two persons had died, one was in hospital due to cataract, two had moved and 19 did not attend. There were no significant differences in sex, in anti-hypertensive medication and in the mean values of 2-h OGTT between the participants and the non-participants. However, a higher mean fasting insulin level (13.7 vs 11.1 mU/l) and a higher mean body mass index (BMI) (28.8 vs 27.1) were observed in the non-participants. The details of the initial survey and the follow-up study have been reported previously. [14] [15] [16] A postal questionnaire concerning the previous history of diabetes, hypertension, anti-hypertensive medication and other questions was sent to each of the participants, and the answers to the questions and the anti-hypertensive agents used previously were checked during the interviews.
Systolic (1st phase of Korotkoff sounds) and diastolic (5th phase) blood pressures were recorded using standard mercury sphygmomanometers after the subjects had rested for more than 30 min in the sitting position. A single BP reading was taken for the subjects with normal BP. A repeated BP measurement was made whenever the first reading was above the defined normal limit, and the second reading was recorded. For every subject, two BP measurements were made separately on the day of interview and when the subject was coming in for a blood glucose test. The mean value of the two measurements was used in this analysis. Drug treatment for hypertension was verified at both the initial survey and at follow-up. If a subject reported taking anti-hypertensive medication at the initial survey, but not at follow-up, the reason was investigated by checking the patient's previous records in the health centre, and a diagnosis of hypertension was made on the basis of the history of the disease. Hypertension was defined as either a systolic BP of у160 mm Hg, or a diastolic BP of у95 mm Hg, or being on anti-hypertensive medication regardless of the BP values. 17 The BMI was calculated by dividing the weight (kg) by the height (m) squared. Changes in the weight between the initial and follow-up surveys were calculated by subtracting the weight at baseline from the weight at follow-up. A positive change means an increase in the weight at follow-up and a negative change means a decrease. The same principle was used in calculating the changes in fasting insulin levels between the two examinations.
A person was defined as a 'smoker' if he/she smoked currently or had quitted smoking during the follow-up period, but had smoked for at least 10 years before. Exercise behaviour was determined by asking the subjects about the frequency, intensity and duration of exercise taken in their leisure time. A sum variable with three scales for exercise behaviour was then formed. Physical inactivity means that exercise was taken once a week or less. Moderate activity means that exercise was taken twice a week or more for half an hour or longer at a time, but without sweat or breathlessness. Vigorous activity indicates that the person did more than moderate exercise with heavy sweat and breathlessness every time. Alcohol consumption was categorised into three groups according to the amount of alcohol consumed within a 2-week period, ie, no drink, drinks Ͻ56 cl and у56 cl.
Laboratory tests
The procedures of laboratory measurements have been described in detail elsewhere. 15 In brief, a standard 75-g OGTT was made according to the 1985 WHO 13 recommendation. After a fast of 10-12 h, a venous blood sample was drawn between 08.00-10.00 am to obtain a fasting value and values for serum insulin, total cholesterol, serum high-density lipoprotein (HDL) cholesterol and triglycerides. After that, a 75-g glucose load (Glucodyn/Leiras) was given to the participants. At 2 h, a single capillary blood sample was collected for the 2-h value. The concentration of blood glucose was determined with the hexokinase-glucose-6-phosphate dehydrogenase method (Merck Diagnostica, Darmstadt, Germany). The coefficients of variation (CV) for within-run studies were between 1.7 and 2.8% depending on the glucose concentration. For day-today studies, the CV was 2.8% at the upper end of the reference range. The times when the blood samples were taken were registered, and the 2-h postload sample was not accepted if it had been drawn more than 5 min too early or too late.
The serum samples for insulin and lipids were deep-frozen (−74°C) until measurement. The serum insulin concentration was measured by radioimmunoassay using Phadeseph Insulin RIA100 (Pharmacia Diagnostics AB, Uppsala, Sweden), which also detects proinsulin and proinsulin conversion products with considerable sensitivity. The cross-reactivity of proinsulin in this assay is about 41%.
Statistical analysis
The statistical analyses were carried out using the SPSS for Windows program version 7.5.1. Student's t-tests and descriptive cross-tabulations were employed to compare the mean values of selected characteristics and to analyse the association of the outcome (hypertension vs normotension) with each categorical variable. In case of skewed variables the geometric means of insulin concentration were presented, based on logarithmic transformations. Multiple logistic regression analyses were performed to investigate the association of hypertension at follow-up (outcome) with baseline fasting insulin level and baseline BMI in a forward stepwise manner separately for subjects with normotension at baseline and for all of the subjects. Glucose tolerance status, sex, BMI, weight change during the follow-up, smoking, exercise behaviour and alcohol consumption were adjusted in each regression model.
Results
Sixteen (18%) of the 91 subjects who were normotensive at baseline had developed hypertension by follow-up. The highest incidence of hypertension was seen among diabetic subjects at follow-up. One diabetic (50%), four (22%) IGT and 11 (16%) normal glucose tolerance subjects developed hypertension during the follow-up. The baseline characteristics of the subjects according to the incidence of hypertension at follow-up are presented in Table 1 . Subjects who developed hypertension at follow-up had higher fasting insulin level and higher BMI at baseline. Table 2 shows the adjusted odds ratios of the association between hypertension and hyperinsulinaemia for subjects normotensive at baseline and for all of the IGT subjects. Elevated fasting insulin concentration at baseline was an independent predictor for the incidence of hypertension at follow-up. Elevated baseline BMI was also a risk for hypertension ( Table 3 ). The baseline fasting insulin concentration was higher in subjects who developed hypertension compared to subjects who were normotensive, and the highest fasting insulin level was seen in obese hypertensive subjects (Table 4) . Table 2 Adjusted odds ratios for the association between hypertension at follow-up (outcome) and fasting insulin concentration (mU/l) at baseline. The odds ratios corresponding to one unit increase in the fasting insulin level
Odds

95% confidence ratios interval
(1) Subjects normotensive at 1.13 1.00-1.28 baseline (n = 91) (2) Normotensive at baseline and 1.22 1.01-1.47 normal glucose tolerance at follow-up (n = 71) (3) All subjects normotensive or 1.15 1.07-1.25 hypertensive at baseline (n = 183) Sex, 2-h blood glucose, total cholesterol, HDL-cholesterol, triglycerides, alcohol consumption, and smoking and exercise behaviour at baseline adjusted each model. 
Discussion
In spite of the high respondent rate for this study, the small sample size and the short period of followup may obscure the observation of interest. And, because the subjects who did not attend the followup survey were more obese and had higher baseline fasting insulin levels than the participants, the risk of hypertension and the observed association between hyperinsulinaemia and hypertension would have been stronger if all subjects had attended the study. In addition, because waist and hip circumferences were not measured at baseline, the association of central obesity with hypertension could not be evaluated and adjusted for. However, the assessment of hypertension status is quite reliable. Firstly, BP was measured two times on different days and the mean of the two measurements was used in the data analysis. Secondly, we rechecked the disease history from case records for all those with inconsistent answers on anti-hypertensive medications and excluded the patients who took drugs with BP-lowering effect for diseases other than hypertension. Subjects with IGT provide a good opportunity to study the association between hypertension and hyperinsulinaemia, since hyperinsulinaemia and insulin resistance are basic characteristics of patients with IGT, [18] [19] [20] and the incidence of IGT is higher in hypertensive patients. 21 In this study, the incidence of hypertension was higher in the subjects with diabetes and IGT compared to the subjects with normal glucose tolerance at follow-up. This suggested the coexistence of hypertension and glucose intolerance, which has been observed in many other studies. [1] [2] [3] [4] [5] [6] An independent association of hyperinsulinaemia with hypertension has also been reported in many other studies. 5, [22] [23] [24] [25] [26] However, most of the studies have been cross-sectional, and thus the presence of hyperinsulinaemia could be a consequence of hypertension or hyperlipidaemia rather than a cause of these disorders. Longitudinal studies to verify the etiologic role of hyperinsulinaemia in the development of hypertension are still scarce. Christlieb et al 5 found a causal relationship between the level of circulating insulin and diastolic BP at the first-year follow-up of subjects with impaired glucose tolerance. Haffner et al 11 observed an independent association in subjects with normal body weight and normoglycaemia. A causal relationship between the elevated fasting insulin concentration and the development of hypertension was found in this study. But, the presence of this association in the general population remains to be demonstrated since the population studied here had a previous history of IGT. Insulin resistance has been thought to raise the BP by increasing renal sodium retention or stimulating the sympathetic nervous system, or both. 27 But the biological plausibility of insulin as a hypertensive agent seems slender. 28 An independent association of obesity and weight gain with hypertension has been observed in many cross-sectional and prospective studies, [29] [30] [31] and several studies have shown that body fat distribution is a more powerful determinant of BP than overall measures of obesity, 32, 33 In this study, the increased BMI preceded the development of hypertension, and correlated positively with the fasting insulin concentration (r = 0.54, P Ͻ 0.001). This may suggest that hyperinsulinaemia is a link between hypertension and obesity and that the association of hypertension with obesity is mediated by hyperinsulinaemia. 1, 5 It is concluded that an elevated fasting insulin concentration as well as an increased BMI preceded the onset of hypertension in subjects with IGT at baseline. It may suggest a causal relationship between hypertension and hyperinsulinemia.
